- Home
- ADCT vs RNGR Comparison
ADCT vs RNGR Comparison
Compare ADCT & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- RNGR
- Stock Information
- Founded
- ADCT 2011
- RNGR 2017
- Country
- ADCT Switzerland
- RNGR United States
- Employees
- ADCT N/A
- RNGR N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- RNGR Oilfield Services/Equipment
- Sector
- ADCT Health Care
- RNGR Energy
- Exchange
- ADCT Nasdaq
- RNGR Nasdaq
- Market Cap
- ADCT 241.0M
- RNGR 279.8M
- IPO Year
- ADCT 2020
- RNGR 2017
- Fundamental
- Price
- ADCT $2.69
- RNGR $12.73
- Analyst Decision
- ADCT Strong Buy
- RNGR Hold
- Analyst Count
- ADCT 6
- RNGR 1
- Target Price
- ADCT $7.80
- RNGR $13.00
- AVG Volume (30 Days)
- ADCT 663.5K
- RNGR 206.8K
- Earning Date
- ADCT 08-12-2025
- RNGR 07-28-2025
- Dividend Yield
- ADCT N/A
- RNGR 1.89%
- EPS Growth
- ADCT N/A
- RNGR 53.19
- EPS
- ADCT N/A
- RNGR 0.99
- Revenue
- ADCT $75,817,000.00
- RNGR $571,900,000.00
- Revenue This Year
- ADCT $11.75
- RNGR $11.70
- Revenue Next Year
- ADCT $8.56
- RNGR N/A
- P/E Ratio
- ADCT N/A
- RNGR $12.90
- Revenue Growth
- ADCT 10.49
- RNGR N/A
- 52 Week Low
- ADCT $1.05
- RNGR $10.56
- 52 Week High
- ADCT $3.97
- RNGR $18.45
- Technical
- Relative Strength Index (RSI)
- ADCT 40.85
- RNGR 51.95
- Support Level
- ADCT $2.84
- RNGR $11.44
- Resistance Level
- ADCT $3.19
- RNGR $15.10
- Average True Range (ATR)
- ADCT 0.19
- RNGR 0.55
- MACD
- ADCT -0.06
- RNGR 0.15
- Stochastic Oscillator
- ADCT 12.66
- RNGR 40.15
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.